Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
  Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?

Ottenhoff, T. H. M., & Kaufmann, S. H. E. (2012). Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go? PLoS Pathogens, 8(5): e1002607. doi:10.1371/journal.ppat.1002607.

Item is

Basisdaten

einblenden: ausblenden:
Genre: Zeitschriftenartikel
Alternativer Titel : PLoS Pathog.

Dateien

einblenden: Dateien
ausblenden: Dateien
:
PLoS_Pathogens_2012_8_e1002607.pdf (Verlagsversion), 248KB
Name:
PLoS_Pathogens_2012_8_e1002607.pdf
Beschreibung:
-
OA-Status:
Sichtbarkeit:
Öffentlich
MIME-Typ / Prüfsumme:
application/pdf / [MD5]
Technische Metadaten:
Copyright Datum:
-
Copyright Info:
Copyright Ottenhoff, Kaufmann. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Lizenz:
-

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Ottenhoff, Tom H. M., Autor
Kaufmann, Stefan H. E.1, Autor           
Affiliations:
1Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society, ou_1664146              

Inhalt

einblenden:
ausblenden:
Schlagwörter: -
 Zusammenfassung: In this review we discuss recent progress in the development, testing, and clinical evaluation of new vaccines against tuberculosis (TB). Over the last 20 years, tremendous progress has been made in TB vaccine research and development: from a pipeline virtually empty of new TB candidate vaccines in the early 1990s, to an era in which a dozen novel TB vaccine candidates have been and are being evaluated in human clinical trials. In addition, innovative approaches are being pursued to further improve existing vaccines, as well as discover new ones. Thus, there is good reason for optimism in the field of TB vaccines that it will be possible to develop better vaccines than BCG, which is still the only vaccine available against TB.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2012-05
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: Expertenbegutachtung
 Identifikatoren: eDoc: 611187
ISI: 000305322900001
DOI: 10.1371/journal.ppat.1002607
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: PLoS Pathogens
  Alternativer Titel : PLoS Pathog.
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: SAN FRANCISCO : PUBLIC LIBRARY SCIENCE
Seiten: - Band / Heft: 8 (5) Artikelnummer: e1002607 Start- / Endseite: - Identifikator: ISSN: 1553-7374